MergerAug 11, 2026, 04:09 PM
Sanara MedTech Amends Merger Agreement with MiMedx Group
AI Summary
Sanara MedTech Inc. filed an amendment to its Agreement and Plan of Merger with MiMedx Group, Inc., correcting previously reported termination fee amounts. The amendment clarifies that Sanara's termination fee is $9,660,336.00 and MiMedx's is $22,540,785.00. The original merger agreement, entered on July 29, 2026, involves Sanara becoming a wholly-owned subsidiary of MiMedx. Sanara shareholders will receive $33.00 in cash and 0.4735 shares of MiMedx common stock per share.
Key Highlights
- Merger Agreement with MiMedx Group, Inc. was entered on July 29, 2026.
- Sanara MedTech shareholders to receive $33.00 in cash per share.
- Sanara MedTech shareholders to receive 0.4735 shares of MiMedx common stock per share.
- Per Share Stock Consideration valued at $2.00 per share.
- Sanara MedTech's termination fee corrected to $9,660,336.00.
- MiMedx Group, Inc.'s termination fee corrected to $22,540,785.00.
- The Board of Directors of Sanara MedTech unanimously approved the merger.
Price Impact
More from SMTI